Yafang Wang
5PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 15, 2026
Targeting PLK1 potentiates the antitumor efficacy of EGFR-TKIs through inhibiting the JAK1/STAT3 pathway.Cheng Li, Shangxuan Shi, Long Li
|Oct 22, 2024
Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.Ziwei Luo, Chencen Lin, Chuwei Yu
|Sep 10, 2024
Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS-mutant Cancers.Yafang Wang, Lansong Xu, Lijun Ling
|Aug 29, 2022
Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer.Ya-Fang Wang, Lei Yu, Zong-Long Hu
Pageof 1
Frequent Collaborators
3 joint publications
Chengying Xie
1 joint publications
Ziwei Luo
1 joint publications
Chencen Lin
1 joint publications
Chuwei Yu
1 joint publications
Changxian Yuan
1 joint publications
Wenyong Wu
1 joint publications
Xiaowei Xu
1 joint publications
Renhong Sun
1 joint publications
Yan Jia
1 joint publications
Jie Shen
